DE69320661D1 - Verfahren zur messung von heparin - Google Patents

Verfahren zur messung von heparin

Info

Publication number
DE69320661D1
DE69320661D1 DE69320661T DE69320661T DE69320661D1 DE 69320661 D1 DE69320661 D1 DE 69320661D1 DE 69320661 T DE69320661 T DE 69320661T DE 69320661 T DE69320661 T DE 69320661T DE 69320661 D1 DE69320661 D1 DE 69320661D1
Authority
DE
Germany
Prior art keywords
measuring heparin
heparin
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69320661T
Other languages
English (en)
Other versions
DE69320661T2 (de
Inventor
Michael Nesheim
Reginald Manuel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of DE69320661D1 publication Critical patent/DE69320661D1/de
Application granted granted Critical
Publication of DE69320661T2 publication Critical patent/DE69320661T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8128—Antithrombin III
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69320661T 1992-06-08 1993-11-05 Verfahren zur messung von heparin Expired - Fee Related DE69320661T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/895,078 US5308755A (en) 1992-06-08 1992-06-08 Method for measuring heparin
PCT/CA1993/000452 WO1995012817A1 (en) 1992-06-08 1993-11-05 Method for measuring heparin

Publications (2)

Publication Number Publication Date
DE69320661D1 true DE69320661D1 (de) 1998-10-01
DE69320661T2 DE69320661T2 (de) 1999-02-11

Family

ID=1340647

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69320661T Expired - Fee Related DE69320661T2 (de) 1992-06-08 1993-11-05 Verfahren zur messung von heparin

Country Status (5)

Country Link
US (1) US5308755A (de)
EP (1) EP0727047B1 (de)
CA (1) CA2174328A1 (de)
DE (1) DE69320661T2 (de)
WO (1) WO1995012817A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002776B (el) * 1996-12-02 1997-09-26 . Εξουδετερωση της αντιπηκτικης δρασης του συμπλεγματος της αντιθρομβινης-ιιι/ ηπαρινης, νεα δοκιμασια αποκαλυψης θρομβοφιλικων καταστασεων
NL1006429C2 (nl) * 1997-06-27 1998-12-29 Univ Maastricht Werkwijze voor het bepalen van het heparinegehalte.
US6194394B1 (en) * 1998-07-01 2001-02-27 Sigma-Aldrich Co. Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
DE10239821A1 (de) * 2002-08-29 2004-03-11 Roche Diagnostics Gmbh Verbesserung der Spezifität bei der Bestimmung von Antithrombin
AU2005243161A1 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor Xa and/or anti factor iia activities
DE102006008613A1 (de) * 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
CN115032164B (zh) * 2022-08-10 2022-12-06 山东省食品药品检验研究院 一种肝素钠中是否含有凝血因子Xa直接抑制剂的检测方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7602422A (nl) * 1976-03-08 1977-09-12 Leuven Res & Dev Vzw Trombosetest.
DE2812943C3 (de) * 1978-03-23 1981-05-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
US4849353A (en) * 1980-09-30 1989-07-18 Cornell Research Foundation, Inc. Immunocapture of enzyme inhibitor, enzyme complexes and uses thereof
US4496653A (en) * 1980-10-09 1985-01-29 Boehringer Mannheim Gmbh Process for the determination of antithrombin-BM
US4543335A (en) * 1982-12-20 1985-09-24 Miles Laboratories, Inc. Device and method for the quantitative determination of heparin in mammalian blood plasma
JPS60241900A (ja) * 1984-05-16 1985-11-30 Nitto Boseki Co Ltd 新規な第Ｘａ因子活性測定用基質
US4668621A (en) * 1985-04-22 1987-05-26 Wake Forest University Detecting blood clotting factors with immobilized fibrinogen and labeled fibrinogen
DE3679763D1 (de) * 1985-09-05 1991-07-18 E Thye Yin Verfahren und zusammensetzungen zur bestimmung von heparin.
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4948724A (en) * 1985-09-05 1990-08-14 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
DE3531778A1 (de) * 1985-09-06 1987-03-12 Behringwerke Ag Verfahren zur bestimmung von proteaseinhibitoren
US4883751A (en) * 1986-05-28 1989-11-28 New York University Specific immunoassay for heparin
US4908314A (en) * 1987-07-02 1990-03-13 American National Red Cross Protein C activator
FR2645647B1 (fr) * 1989-04-07 1991-07-05 Stago Diagnostica Procede de dosage de complexes antithrombine-proteases
JP3094165B2 (ja) * 1990-11-05 2000-10-03 バクスター、ダイアグノスチックス、インコーポレイテッド 抗凝固剤濃度測定方法
GB9119102D0 (en) * 1991-09-07 1991-10-23 Biosyn Ltd Bioimmunassay

Also Published As

Publication number Publication date
US5308755A (en) 1994-05-03
DE69320661T2 (de) 1999-02-11
CA2174328A1 (en) 1995-05-11
WO1995012817A1 (en) 1995-05-11
EP0727047A1 (de) 1996-08-21
EP0727047B1 (de) 1998-08-26

Similar Documents

Publication Publication Date Title
DE69409513D1 (de) Verfahren zur geometrischen messung
DE68929525D1 (de) Verfahren zur Messung von Verunreinigungen
DE69328273D1 (de) Verfahren zur Messung von glykosiliertem Hämoglobin
DE69132170D1 (de) Verfahren zur Abstandsmessung
DE69113186D1 (de) Verfahren zur Messung der Modulationsgenauigkeit.
DE69124312D1 (de) Verfahren zur Prüfung von Fingerabdrücken
DE59205867D1 (de) Verfahren zur Erkennung von Verbrennungsaussetzern
DE4403348B8 (de) Verfahren zur Detektion von Fehlzündungen
DE69119610D1 (de) Verfahren zur mikro-einkapselung von hyperbarem gas
DE59007526D1 (de) Verfahren und system zur messdatenerfassung und -auswertung.
DE59401597D1 (de) Verfahren zur Überwachung von beweglichen Elementen
DE69309889D1 (de) Verfahren zur erkennung von fehlzündungen
DE59204440D1 (de) Verfahren zur Erkennung von Verbrennungsaussetzern.
DE59306790D1 (de) Verfahren zur Überprüfung von Lambdasonden
DE69630686D1 (de) Verfahren zur echtheitsprüfung von münzen
DE69120359D1 (de) Verfahren zur identifizierung von candida albicans mittels chromogener substanzen
DE69617773D1 (de) Verfahren zur Messung von Oligonukleotidabbau
DE58901197D1 (de) Verfahren zur weg- und winkelmessung.
DE58901447D1 (de) Verfahren zur lagegenauen befestigung von ausruestungsteilen.
DE69129732D1 (de) Verfahren zur Positionsdetektion
DE69427115D1 (de) Verfahren zur messung der antithrombin-iii-aktivität
DE69123445D1 (de) Verfahren zur bestimmung von endotoxinen
DE69713842D1 (de) Verfahren zur Messung der Position von optischen Transmissionselementen
DE69320661D1 (de) Verfahren zur messung von heparin
DE3871168D1 (de) Verfahren zur messung von biomasse.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee